Direct Answer

West Pharmaceutical Services reports revenue across 2 business segments in its fiscal 2025 Form 10-K. Proprietary Products is the largest, with $2.5 billion of revenue (81% of the total), followed by Contract Manufactured Products at $582 million (19%). 43% of revenue came from the United States.

How Does West Pharmaceutical Services Make Money?

Proprietary Products supplies 81% of revenue, so West Pharmaceutical Services's results move mostly with that one business; the others matter more for diversification than for the headline number. Between fiscal 2024 and 2025, Proprietary Products grew fastest (+6.8%) and Contract Manufactured Products slowest (+4.2%), so the revenue mix tilts toward Proprietary Products while that gap lasts.

SegmentFY2025 revenueFY2024 revenueShare of revenueChange
Proprietary Products$2.5 billion$2.3 billion81.1%6.8%
Contract Manufactured Products$582 million$559 million18.9%4.2%
Bar chart of West Pharmaceutical Services revenue by segment for fiscal 2025: Proprietary Products 81.1%, Contract Manufactured Products 18.9%.
West Pharmaceutical Services revenue by segment as a share of total revenue, from the table above. The largest is highlighted. Select the chart to open it full size.

Which West Pharmaceutical Services Segments Earn the Most?

SegmentFY2025 segment operating incomeSegment margin
Proprietary Products$657 million26.4%
Contract Manufactured Products$63 million10.9%

Segment operating income is the profit measure West Pharmaceutical Services reports to its chief operating decision maker for each segment. It usually leaves out corporate costs that are not allocated to a segment, so the segments usually add up to more than consolidated operating income, and margins are comparable within West Pharmaceutical Services more safely than against another company.

Where Does West Pharmaceutical Services's Revenue Come From?

Regions follow the definitions in the filing; most companies assign revenue by customer location.

RegionFY2025 revenueFY2024 revenueShare of revenueChange
United States$1.3 billion$1.2 billion43.3%8.0%
Other Europe Countries$451 million$386 million14.7%17.0%
Germany$380 million$373 million12.4%2.1%
Other countries$353 million$339 million11.5%4.2%
Ireland$333 million$323 million10.8%3.1%
France$227 million$242 million7.4%-6.4%

What the Segment Figures Do Not Show

The rows above add up to 100% of West Pharmaceutical Services's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.

Where These Numbers Come From

Every figure on this page is a value West Pharmaceutical Services reported in the segment note and revenue disclosures of its Form 10-K filed February 17, 2026 (accession 0000105770-26-000010), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.

Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.

Frequently Asked Questions

What are West Pharmaceutical Services's business segments?

In its fiscal 2025 Form 10-K, West Pharmaceutical Services reports revenue for Proprietary Products and Contract Manufactured Products.

Which part of West Pharmaceutical Services brings in the most revenue?

Proprietary Products, with $2.5 billion of revenue in fiscal 2025, or 81% of the total.

How much of West Pharmaceutical Services's revenue comes from outside the United States?

57% in fiscal 2025, by the geographic breakdown West Pharmaceutical Services reports in its Form 10-K. Companies assign revenue to regions differently (customer location, shipping address or selling entity), so check the filing's definition before comparing companies.

References

Related Pages